Calcipotriol/LEO-80122

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCalcipotriol/LEO-80122
Drug Alias Namecalcipotriene/LEO-80122LEO-80122/CalcipotriolLEO-80122 and CalcipotriolCalcipotriol and LEO-80122LEO-19123
ClassificationSmall molecules
Mechanisms of ActionVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsPsoriasisEczemaDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaDenmarkUnited Kingdom +[4] 
CombinationsYes Calcipotriol
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeo Pharma Inc
Active IndicationsN/A
Inactive IndicationsPsoriasisEczemaDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A